Variant report
Variant | rs4819219 |
---|---|
Chromosome Location | chr21:44984864-44984865 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr21:44984814-44985471 | Gliobla | brain: | n/a | n/a |
2 | POLR2A | chr21:44984786-44985493 | HUVEC | blood vessel: | n/a | n/a |
3 | POLR2A | chr21:44984765-44985505 | MCF-7 | breast: | n/a | n/a |
4 | POLR2A | chr21:44984797-44985506 | GM12878 | blood: | n/a | n/a |
5 | POLR2A | chr21:44984779-44985722 | GM12892 | blood: | n/a | n/a |
6 | POU2F2 | chr21:44984850-44985561 | GM12878 | blood: | n/a | n/a |
7 | POLR2A | chr21:44984827-44985768 | GM12892 | blood: | n/a | n/a |
8 | POLR2A | chr21:44984764-44985587 | K562 | blood: | n/a | n/a |
9 | POLR2A | chr21:44984762-44985866 | Hela-S3 | cervix: | n/a | n/a |
10 | POLR2A | chr21:44984778-44985473 | A549 | lung: | n/a | n/a |
11 | SPI1 | chr21:44984830-44985202 | HL-60 | blood: | n/a | chr21:44985065-44985078 chr21:44985066-44985075 |
12 | POLR2A | chr21:44984861-44985676 | GM12892 | blood: | n/a | n/a |
13 | POLR2A | chr21:44984808-44985504 | MCF-7 | breast: | n/a | n/a |
14 | POLR2A | chr21:44984821-44985495 | MCF-7 | breast: | n/a | n/a |
15 | POLR2A | chr21:44984777-44985967 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
H2BFS | TF binding region |
rs_ID | r2[population] |
---|---|
rs1003280 | 0.87[CHB][hapmap] |
rs1073522 | 0.87[CHB][hapmap];1.00[YRI][hapmap];0.92[AFR][1000 genomes] |
rs11089020 | 0.84[ASN][1000 genomes] |
rs1122873 | 0.87[CHB][hapmap];1.00[YRI][hapmap];0.88[AFR][1000 genomes] |
rs11701518 | 0.93[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11701746 | 0.96[ASN][1000 genomes] |
rs12165286 | 0.85[YRI][hapmap] |
rs12626757 | 0.85[AFR][1000 genomes] |
rs12627667 | 0.87[CHB][hapmap] |
rs1378079 | 0.87[CHB][hapmap] |
rs1378080 | 0.87[CHB][hapmap];0.83[YRI][hapmap] |
rs141521 | 0.87[CHB][hapmap] |
rs1436291 | 0.96[ASN][1000 genomes] |
rs1454648 | 0.87[CHB][hapmap] |
rs1454650 | 0.87[CHB][hapmap] |
rs1454651 | 0.87[CHB][hapmap] |
rs1584917 | 0.86[CHB][hapmap] |
rs1584918 | 0.86[CHB][hapmap];0.84[YRI][hapmap];0.83[AFR][1000 genomes] |
rs1595167 | 0.96[ASN][1000 genomes] |
rs1598206 | 0.87[CHB][hapmap] |
rs162344 | 0.87[CHB][hapmap] |
rs162345 | 0.87[CHB][hapmap] |
rs162366 | 0.87[CHB][hapmap];0.95[YRI][hapmap] |
rs162371 | 0.87[CHB][hapmap] |
rs162372 | 0.87[CHB][hapmap];0.91[YRI][hapmap] |
rs162375 | 0.87[CHB][hapmap];0.95[YRI][hapmap] |
rs162376 | 0.87[CHB][hapmap];0.90[YRI][hapmap] |
rs162377 | 0.87[CHB][hapmap];0.95[YRI][hapmap] |
rs162378 | 0.87[CHB][hapmap] |
rs162380 | 0.91[YRI][hapmap] |
rs162388 | 0.87[CHB][hapmap] |
rs162390 | 0.91[YRI][hapmap] |
rs162399 | 0.91[YRI][hapmap] |
rs162400 | 0.95[YRI][hapmap] |
rs162403 | 0.89[AFR][1000 genomes] |
rs1836854 | 0.96[ASN][1000 genomes] |
rs1836855 | 0.96[ASN][1000 genomes] |
rs1836856 | 0.85[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[ASN][1000 genomes] |
rs2246602 | 0.87[CHB][hapmap] |
rs229357 | 0.87[CHB][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes] |
rs230642 | 0.90[YRI][hapmap] |
rs2329442 | 0.87[CHB][hapmap];0.83[YRI][hapmap];0.83[AFR][1000 genomes] |
rs2838315 | 0.84[EUR][1000 genomes] |
rs2838316 | 0.87[CHB][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes] |
rs2838317 | 0.87[CHB][hapmap] |
rs2838319 | 0.87[CHB][hapmap] |
rs2838320 | 1.00[YRI][hapmap];0.93[AFR][1000 genomes] |
rs2838321 | 0.87[CHB][hapmap] |
rs2838322 | 0.92[AFR][1000 genomes] |
rs2838323 | 0.87[CHB][hapmap] |
rs2838324 | 0.87[CHB][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes] |
rs2838328 | 0.87[CHB][hapmap] |
rs2838329 | 0.81[AFR][1000 genomes] |
rs2838330 | 0.87[CHB][hapmap] |
rs2838331 | 0.87[CHB][hapmap];0.87[YRI][hapmap];0.83[AFR][1000 genomes] |
rs2838336 | 0.87[CHB][hapmap] |
rs2838337 | 0.87[CHB][hapmap];1.00[YRI][hapmap] |
rs2838338 | 0.87[CHB][hapmap] |
rs2838339 | 0.87[CHB][hapmap];1.00[YRI][hapmap] |
rs2838341 | 0.87[CHB][hapmap] |
rs2838343 | 0.87[CHB][hapmap] |
rs2876854 | 1.00[ASN][1000 genomes] |
rs3788062 | 0.87[CHB][hapmap] |
rs4818850 | 0.86[CHB][hapmap] |
rs4818856 | 0.84[AFR][1000 genomes] |
rs4819212 | 1.00[CHB][hapmap];0.94[JPT][hapmap];0.90[ASN][1000 genomes] |
rs4819264 | 0.81[AFR][1000 genomes] |
rs4819270 | 0.93[CHB][hapmap];0.88[YRI][hapmap];0.82[AFR][1000 genomes] |
rs56369437 | 0.96[ASN][1000 genomes] |
rs6417729 | 0.90[AFR][1000 genomes];0.82[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs6518268 | 0.96[ASN][1000 genomes] |
rs6518301 | 0.87[CHB][hapmap] |
rs6518302 | 0.87[CHB][hapmap];1.00[YRI][hapmap];0.85[AFR][1000 genomes] |
rs6518309 | 0.87[CHB][hapmap] |
rs7276215 | 0.86[CHB][hapmap];1.00[YRI][hapmap];0.93[AFR][1000 genomes] |
rs7276633 | 0.87[CHB][hapmap] |
rs7277539 | 0.87[YRI][hapmap] |
rs7278003 | 0.89[AFR][1000 genomes];0.81[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs7278282 | 0.92[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7279958 | 0.87[CHB][hapmap] |
rs7279968 | 0.87[CHB][hapmap] |
rs7282704 | 0.95[ASN][1000 genomes] |
rs7282933 | 0.87[AFR][1000 genomes] |
rs7283362 | 0.84[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.96[ASN][1000 genomes] |
rs8131020 | 0.92[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8133523 | 0.87[CHB][hapmap];1.00[YRI][hapmap] |
rs86139 | 0.87[CHB][hapmap] |
rs9306159 | 0.87[CHB][hapmap];0.84[YRI][hapmap] |
rs9976441 | 0.87[CHB][hapmap] |
rs9977258 | 0.91[AFR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs9978811 | 0.86[CHB][hapmap] |
rs9978934 | 0.91[YRI][hapmap] |
rs9979187 | 0.85[ASN][1000 genomes] |
rs9979935 | 0.91[YRI][hapmap] |
rs9981291 | 0.87[CHB][hapmap];0.82[YRI][hapmap];0.83[AFR][1000 genomes] |
rs9981790 | 0.84[CHB][hapmap] |
rs9983752 | 1.00[YRI][hapmap] |
rs9983763 | 0.87[CHB][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv913873 | chr21:44879869-45142427 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 64 gene(s) | inside rSNPs | diseases |
2 | nsv587689 | chr21:44884252-44986050 | Weak transcription Enhancers Genic enhancers ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Strong transcription Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 36 gene(s) | inside rSNPs | diseases |
3 | nsv1061539 | chr21:44915533-45041824 | Weak transcription ZNF genes & repeats Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Active TSS Genic enhancers Active TSS Flanking Bivalent TSS/Enh Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 22 gene(s) | inside rSNPs | diseases |
4 | nsv1067171 | chr21:44921187-45039471 | Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Genic enhancers ZNF genes & repeats Strong transcription Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 22 gene(s) | inside rSNPs | diseases |
5 | nsv521700 | chr21:44925334-45041790 | Enhancers Weak transcription Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 17 gene(s) | inside rSNPs | diseases |
6 | nsv470903 | chr21:44925334-45061501 | Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 17 gene(s) | inside rSNPs | diseases |
7 | nsv459289 | chr21:44925334-45064600 | Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 18 gene(s) | inside rSNPs | diseases |
8 | nsv587690 | chr21:44925334-45064600 | Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 18 gene(s) | inside rSNPs | diseases |
9 | esv1837818 | chr21:44949285-44987079 | Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
10 | nsv511632 | chr21:44963686-44987079 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
11 | nsv1065359 | chr21:44967209-45029878 | Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 5 gene(s) | inside rSNPs | diseases |
12 | nsv3537 | chr21:44967340-45013104 | Flanking Active TSS Enhancers Strong transcription Weak transcription Bivalent Enhancer Active TSS ZNF genes & repeats Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
13 | nsv965984 | chr21:44983478-44987141 | Weak transcription Strong transcription Active TSS ZNF genes & repeats Enhancers Flanking Active TSS | TF binding regionCpG island | 1 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:44980400-44998400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr21:44982800-44988200 | Weak transcription | HSMM | muscle |
3 | chr21:44983000-44986600 | Weak transcription | Esophagus | oesophagus |
4 | chr21:44983000-44991800 | Weak transcription | Placenta Amnion | Placenta Amnion |
5 | chr21:44983000-44993400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr21:44983400-44986200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr21:44983600-44985000 | Strong transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr21:44984000-44990600 | Weak transcription | Fetal Brain Female | brain |
9 | chr21:44984200-44985000 | Strong transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr21:44984200-44985400 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr21:44984200-44985600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr21:44984400-44985400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr21:44984600-44985200 | Strong transcription | HSMMtube | muscle |
14 | chr21:44984800-44985000 | Enhancers | Adipose Nuclei | Adipose |
15 | chr21:44984800-44985000 | ZNF genes & repeats | A549 | lung |